{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T22:54:35Z","timestamp":1785538475066,"version":"3.56.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"publisher","award":["H2024206081"],"award-info":[{"award-number":["H2024206081"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012505","name":"Hebei Medical University","doi-asserted-by":"publisher","award":["2022LCTD-B27"],"award-info":[{"award-number":["2022LCTD-B27"]}],"id":[{"id":"10.13039\/501100012505","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012505","name":"Hebei Medical University","doi-asserted-by":"publisher","award":["GZ2024040"],"award-info":[{"award-number":["GZ2024040"]}],"id":[{"id":"10.13039\/501100012505","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jpba.2024.116405","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T04:19:42Z","timestamp":1723090782000},"page":"116405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Development of an hollow fiber solid phase microextraction method for the analysis of unbound fraction of imatinib and N-desmethyl imatinib in human plasma"],"prefix":"10.1016","volume":"250","author":[{"given":"Wei-Chong","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Yu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Lun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Liang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Ze","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2024.116405_bib1","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","article-title":"Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia","volume":"344","author":"Druker","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpba.2024.116405_bib2","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/j.1365-2125.2012.04422.x","article-title":"Prediction of free imatinib concentrations based on total plasma concentrations in patients with gastrointestinal stromal tumours","volume":"75","author":"Haouala","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2024.116405_bib3","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/FTD.0b013e3182263ac4","article-title":"Use of total and unbound imatinib and metabolite LC-MS\/MS assay to understand individual responses in CML and GIST patients","volume":"33","author":"Streit","year":"2011","journal-title":"Ther. Drug. Monit."},{"key":"10.1016\/j.jpba.2024.116405_bib4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/FTD.0b013e31823cdec9","article-title":"The role of therapeutic drug monitoring of imatinib in patients with chronic myeloid leukemia and metastatic or unresectable gastrointestinal stromal tumors","volume":"34","author":"Teng","year":"2012","journal-title":"Ther. Drug. Monit."},{"key":"10.1016\/j.jpba.2024.116405_bib5","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1038\/sj.bjc.6604355","article-title":"Relationship of imatinib-free plasma levels and target genotype with efficacy and tolerability","volume":"98","author":"Widmer","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jpba.2024.116405_bib6","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/sj.bjc.6605584","article-title":"Imatinib plasma levels: correlation with clinical benefit in GIST patients","volume":"102","author":"Widmer","year":"2010","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jpba.2024.116405_bib7","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.drudis.2011.12.018","article-title":"Compilation of 222 drugs' plasma protein binding data and guidance for study designs","volume":"17","author":"Zhang","year":"2012","journal-title":"Drug. Discov. Today"},{"key":"10.1016\/j.jpba.2024.116405_bib8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1365-2125.2006.02719.x","article-title":"Population pharmacokinetics of imatinib and the role of alpha-acid glycoprotein","volume":"62","author":"Widmer","year":"2006","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2024.116405_bib9","doi-asserted-by":"crossref","first-page":"854","DOI":"10.3389\/fphar.2019.00854","article-title":"Genetic polymorphisms and adverse events on unbound imatinib and its active metabolite concentration in patients with gastrointestinal stromal tumors","volume":"10","author":"Qian","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jpba.2024.116405_bib10","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00280-012-2035-3","article-title":"Should therapeutic drug monitoring of the unbound fraction of imatinib and its main active metabolite N-desmethyl-imatinib be developed?","volume":"71","author":"Gandia","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jpba.2024.116405_bib11","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jpba.2015.05.008","article-title":"A validated LC-MS\/MS method of total and unbound lenvatinib quantification in human serum for protein binding studies by equilibrium dialysis","volume":"114","author":"Mano","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2024.116405_bib12","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/FTD.0000000000000535","article-title":"Simple LC-MS\/MS methods using core-shell octadecylsilyl microparticulate for the quantitation of total and free daptomycin in human plasma","volume":"40","author":"Miyadera","year":"2018","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jpba.2024.116405_bib13","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/jac\/dkac400","article-title":"Comparison of ultrafiltration and microdialysis for ceftriaxone protein-binding determination","volume":"78","author":"Sanz-Codina","year":"2023","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jpba.2024.116405_bib14","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jchromb.2012.09.007","article-title":"Determination of unbound fraction of imatinib and N-desmethyl imatinib, validation of an UPLC-MS\/MS assay and ultrafiltration method","volume":"907","author":"Arellano","year":"2012","journal-title":"J. Chromatogr. B. Anal. Technol. Biomed. Life\u00a0Sci."},{"key":"10.1016\/j.jpba.2024.116405_bib15","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/j.jchromb.2011.05.012","article-title":"Developing a robust ultrafiltration-LC\u2013MS\/MS method for quantitative analysis of unbound vadimezan (ASA404) in human plasma","volume":"879","author":"Li","year":"2011","journal-title":"J. Chromatogr. B. Anal. Technol. Biomed. Life\u00a0Sci."},{"key":"10.1016\/j.jpba.2024.116405_bib16","doi-asserted-by":"crossref","first-page":"7369","DOI":"10.1039\/c3an01244a","article-title":"The influence of volume ratio of ultrafiltrate of sample on the analysis of non-protein binding drugs in human plasma","volume":"138","author":"Dong","year":"2013","journal-title":"Analyst"},{"key":"10.1016\/j.jpba.2024.116405_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2012.11.006","article-title":"Effect of volume ratio of ultrafiltrate to sample solution on the analysis of free drug and measurement of free carbamazepine in clinical drug monitoring","volume":"48","author":"Dong","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2024.116405_bib18","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S0022-3549(15)00177-X","article-title":"Application of cassette ultracentrifugation using non-labeled compounds and liquid chromatography-tandem mass spectrometry analysis for high- throughput protein binding determination","volume":"105","author":"Kieltyka","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2024.116405_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2023.125223","article-title":"Hierarchical covalent organic framework hollow nanofibers-bonded stainless steel fiber for efficient solid phase microextraction","volume":"267","author":"Fang","year":"2024","journal-title":"Talanta"},{"key":"10.1016\/j.jpba.2024.116405_bib20","article-title":"Hollow fiber-solid phase microextraction of fatty acid methyl esters from wastewater coupled with micro sample collector assisted injection technique","volume":"2023","author":"Liu","year":"1710","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2024.116405_bib21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.chroma.2018.04.040","article-title":"Multiwall carbon nanotube-zirconium oxide nanocomposite hollow fiber solid phase microextraction for determination of polyaromatic hydrocarbons in water, coffee and tea samples","volume":"1554","author":"Yazdi","year":"2018","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2024.116405_bib22","article-title":"Development of a method of hollow fiber-based solid-phase microextraction followed by ultra performance liquid chromatography-tandem mass spectrometry for determination of five antipsychotics in human whole blood and urine","volume":"2020","author":"Li","year":"1620","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2024.116405_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2022.133217","article-title":"Hollow fiber membrane-protected amino\/hydroxyl bifunctional microporous organic network fiber for solid-phase microextraction of bisphenols A, F, S, and triclosan in breast milk and infant formula","volume":"390","author":"Li","year":"2022","journal-title":"Food Chem."},{"key":"10.1016\/j.jpba.2024.116405_bib24","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1365-2125.2004.02117.x","article-title":"In vitro blood distribution and plasma protein binding of the tyrosine kinase inhibitor imatinib and its active metabolite, CGP74588, in rat, dog, monkey, healthy humans and patients with acute myelogenous leukemia","volume":"58","author":"Kretz","year":"2004","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2024.116405_bib25","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1023\/A:1024406221962","article-title":"Modulation of nonspecific binding in ultrafiltration protein binding studies","volume":"20","author":"Lee","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jpba.2024.116405_bib26","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jpba.2005.10.031","article-title":"Modification of the ultrafiltration technique to overcome solubility and non-specific binding challenges associated with the measurement of plasma protein binding of corticosteroids","volume":"41","author":"Taylor","year":"2006","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2024.116405_bib27","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.chroma.2005.12.103","article-title":"Determination of unbound docetaxel and paclitaxel in plasma by ultrafiltration and liquid chromatography-tandem mass spectrometry","volume":"1108","author":"Mortier","year":"2006","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2024.116405_bib28","article-title":"Green profile tools: current status and future perspectives","volume":"6","author":"Locatelli","year":"2023","journal-title":"Adv. Sample Prep."},{"key":"10.1016\/j.jpba.2024.116405_bib29","doi-asserted-by":"crossref","first-page":"10076","DOI":"10.1021\/acs.analchem.0c01887","article-title":"AGREE-analytical GREEnness metric approach and software","volume":"92","author":"Pena-Pereira","year":"2020","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2024.116405_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2022.116553","article-title":"AGREEprep -analytical greenness metric for sample preparation","volume":"149","author":"Wojnowski","year":"2022","journal-title":"TrAC Trends Anal. Chem."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073170852400445X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073170852400445X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T11:29:35Z","timestamp":1751455775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073170852400445X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":30,"alternative-id":["S073170852400445X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116405","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of an hollow fiber solid phase microextraction method for the analysis of unbound fraction of imatinib and N-desmethyl imatinib in human plasma","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116405","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116405"}}